Financials
Value Q2, 25Q3, 25 TTM Selling/general/admin expenses 973 K571 K — Research & development —— — Operating income 17.65 M19.92 M — Non-Operating Income, Total 449 K471 K — Interest expense, net of interest capitalized 13.71 M13.7 M — Non-Operating Income, excl. Interest Expenses -13.27 M-13.23 M — Unusual income/expense —— — Pretax income 7.03 M8.78 M — Equity in earnings —— — Taxes 1.06 M2.04 M — Non-controlling/minority interest —— — After tax other income/expense —— — Net income before discontinued operations 5.96 M6.74 M — Discontinued operations —— — Net income 5.96 M6.74 M — Dilution adjustment —— — Preferred dividends —— — Diluted net income available to common stockholders 5.96 M6.74 M — Basic earnings per share (Basic EPS) 0.580.57 — Diluted earnings per share (Diluted EPS) 0.570.54 — Average basic shares outstanding 10.28 M11.94 M — Diluted shares outstanding 10.61 M12.33 M — EBITDA 17.66 M20.04 M — EBIT 17.37 M19.63 M — Cost of revenue 752 K653 K — Other cost of goods sold —— — Depreciation & amortization (cash flow) 291 K407 K —